Taken collectively, PEA and its congeners could represent an innovative therapeutic tactic while in the management of mixed neuropathies. Knowledge of exogenous PEA pharmacokinetics is still at an early phase [212]. Long term analysis ought to assess the precise tissue distribution and web-site of metabolism of PEA so as https://whatischronicpain66531.blogdon.net/an-unbiased-view-of-palmitoylethanolamide-46607257